Breast Cancer Reirradiation Practice Patterns: An International Survey From the Reirradiation Collaborative Group (ReCOG)
Practical Radiation Oncology · 2026-09 · 16 (5) · e374-e380
DOI: 10.1016/j.prro.2026.03.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Practical Radiation Oncology, 2026-09. Verfasst von Linda Hong und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: hongl@mskcc.org. Hauptthemen laut MEDLINE: Breast Neoplasms, Re-Irradiation, Practice Patterns, Physicians', Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, Memorial Sloan Kettering Cancer Center.
Abstract (Originalsprache)
PURPOSE: Reirradiation (reRT) for locally or regionally recurrent breast cancer is increasingly considered, but practice patterns remain heterogeneous. This study reports results from an international Reirradiation Collaborative Group (ReCOG) survey evaluating contemporary clinical reRT practices and key knowledge gaps in optimal breast reRT approaches. METHODS AND MATERIALS: Radiation oncologists, medical physicists, and dosimetrists with expertise in breast radiation therapy completed a structured ReCOG survey between February 2024 and June 2025. Respondents were asked about patient selection, factors influencing the choice between second breast-conserving therapy and mastectomy, reRT dose-fractionation schedules, planning methods, and knowledge gaps affecting clinical decision making. RESULTS: Thirty-seven respondents participated, from Europe (n = 19), North America (n = 14), and other regions (n = 4), representing 32 identifiable institutions. The most common reasons for not offering reRT included high risk of major side effects from prior radiation therapy such as fibrosis or lymphedema (40%), short relapse interval (33%), or limited life expectancy (17%). Among patients receiving reRT, fibrosis (31%), pain (17%), and arm lymphedema (14%) were reported as the most impactful toxicities on quality of life. Conventional fractionation (45-60 Gy in 1.8 to 2 Gy fractions over 23-30 fractions) was the most frequently selected regimen, followed by moderate hypofractionated schedules (40 Gy in 15 fractions). One respondent reported using twice daily dose of 40 to 50Gy in 1.25 to 1.5Gy fractions. External-beam photon techniques were the predominant modality, with intensity modulated radiation therapy/volumetric modulated arc therapy preferred, while proton therapy and brachytherapy were used selectively. Hyperthermia use was limited (n = 7). Most respondents (80%) performed plan summation when prior DICOM radiation therapy data were available, but specific methods varied. Organs of interest (OOI) dose guidance was most consistently applied for the brachial plexus, heart, lungs, and skin, although thresholds differed widely. The top 3 knowledge gaps identified were as follows: (1) long-term toxicity and oncologic outcome data, (2) standardized and validated OOI dose guidance, and (3) consensus on optimal reRT dose-fractionation schedules, and the scarcity of prospective trials. CONCLUSIONS: This ReCOG survey reveals substantial heterogeneity in breast cancer reRT practices. The identified knowledge gaps highlight the need for standardized clinical guidelines and practical clinical toolsets to support decision making in patient selection, technical planning, and OOI dose guidance to improve outcomes for patients undergoing reRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: hongl@mskcc.org.
- Department of Radiation Oncology, Iridium Network and University of Antwerp, Antwerp, Belgium.
- Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
- Premier Radiation Oncology Associates, Clearwater, Florida.
- Department of Radiation Oncology, UNC School of Medicine, Chapel Hill, North Carolina.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Förderung
- NCI NIH HHS
- National Institutes of Health
- Memorial Sloan Kettering Cancer Center
Zitieren
APA
Hong, L., Poortmans, P., Aznar, M., Brooks, E. D., Casey, D., Choi, J. I., Corradini, S., Jagsi, R., Keilty, D., Koch, A., Kronborg, C., Kubeczko, M., McClatchy, D., Popovic, M., Salerno, K. E., Shaitelman, S. F., Sharma, M., Tsang, Y., Mayo, C., & Gabryś, D. (2026). Breast Cancer Reirradiation Practice Patterns: An International Survey From the Reirradiation Collaborative Group (ReCOG). Practical Radiation Oncology, 16(5), e374-e380. https://doi.org/10.1016/j.prro.2026.03.012
Vancouver
Hong L, Poortmans P, Aznar M, Brooks ED, Casey D, Choi JI, et al. Breast Cancer Reirradiation Practice Patterns: An International Survey From the Reirradiation Collaborative Group (ReCOG). Practical Radiation Oncology. 2026;16(5):e374-e380. doi:10.1016/j.prro.2026.03.012
BibTeX
@article{Hong2026,
author = {Hong, Linda and Poortmans, Philip and Aznar, Marianne and Brooks, Eric D and Casey, Dana and Choi, J Isabelle and Corradini, Stefanie and Jagsi, Reshma and Keilty, Dana and Koch, Anne and Kronborg, Camilla and Kubeczko, Marcin and McClatchy, David and Popovic, Marija and Salerno, Kilian E and Shaitelman, Simona F and Sharma, Manju and Tsang, Yat and Mayo, Charles and Gabryś, Dorota},
title = {Breast Cancer Reirradiation Practice Patterns: An International Survey From the Reirradiation Collaborative Group (ReCOG)},
journal = {Practical Radiation Oncology},
year = {2026},
volume = {16},
number = {5},
pages = {e374--e380},
doi = {10.1016/j.prro.2026.03.012}
}
EUVIMED